iPSC discovery services

Censo Bio is a specialist discovery services company using human stem cells (iPSC) to support neurodegenerative, neuro-inflammation and rare disease focused discovery

Censo provides access to a diverse range of existing human iPSC lines, and ethically sources relevant human tissue, both healthy and with disease specific mutations, with which reprogramme to new iPSC lines

We can gene edit human iPSC lines to knock in, knock out or correct target genes of interest using CRISPR, and have developed reproducible differentiation protocols for a number of lineages, including microglia, astrocytes, cortical and sensory neurons

Using these cells for neurodegenerative and neuroinflammatory disease discovery, we offer customisable phenotypic assays to deliver disease relevant compound characterisation, providing new insights and functional disease related understanding of our clients compounds

We provide a full spectrum of services from creating iPSC lines (iPSC reprogramming), iPSC gene editing, neurodegenerative and neuroinflammation target validation, assay development and compound testing

iPSC Reprogramming

We are experts in the generation and expansion of induced pluripotent stem cells (iPSCs)

iPSC Gene Editing

We offer a range of technologies to custom gene edit iPSC lines

iPSC Discovery Services

iPSC Differentiation and Drug Discovery Assay Services